Siste måned
30 dager
+1 902 330
NETTO POSISJON (NOK)
Handler
7
Kjøp
1 902 330
Salg
0
6 måneder
180 dager
+1 902 330
NETTO POSISJON (NOK)
Handler
13
Kjøp
1 902 330
Salg
0
Historikk
ℹ️ Om innsidehandel
Primærinnsidere er personer med ledelsesansvar og deres nærstående. Meldeplikt inntrer når transaksjoner når EUR 5 000 i et kalenderår.
Meldefrist: umiddelbart, senest tre virkedager. Handelsforbud 30 dager før pliktig finansiell rapportering.
Transaksjoner
Mer info 👉
| Dato | Innsider | Antall | Pris | Verdi |
|---|---|---|---|---|
| 22.09.2026 |
Øystein Soug
Chief Executive Officer
|
142 | 90.00 | 12 780 |
| 22.09.2026 |
Øystein Soug
Chief Executive Officer
via Abakus Invest AS
|
3 333 | 90.00 | 299 970 |
| 22.09.2026 |
Ramzi Amri
Chief Financial Officer
|
3 000 | 90.00 | 270 000 |
| 22.09.2026 |
Kari Grønås
Member of the Board of Directors
via K OG K AS
|
332 | 90.00 | 29 880 |
| 22.09.2026 |
Gro Hjellum
Chief Operating Officer
|
500 | 90.00 | 45 000 |
| 22.09.2026 |
Ingrid Akay
Member of the Board of Directors
via Teakay Invest AS
|
3 984 | 90.00 | 358 560 |
| 22.09.2026 |
Charles Gillies O'Bryan-Tear
Chairman of the Board of Directors
|
9 846 | 90.00 | 886 140 |
| 20.05.2026 |
Kari Grønås
Board member
|
854 | - | - |
| 20.05.2026 |
Olav Hellebø
Board member
|
1 408 | - | - |
| 20.05.2026 |
Orlando Oliveira
Board member
|
854 | - | - |
| 20.05.2026 |
Charles Gillies O'Bryan-Tear
Chairperson of the Board
|
1 708 | - | - |
| 20.05.2026 |
Hilde Steineger
Board member
|
854 | - | - |
| 20.05.2026 |
Johan Häggblad
Board member
|
854 | - | - |
| 11.03.2026 |
Øystein Soug
CEO
|
31 884 | - | - |
| 12.01.2026 |
Ramzi Amri
CFO
|
5 430 000 | 0.50 | 2 715 000 |
| Vis færre ▲ | ||||
Vis alle 15 transaksjoner
▼
Pressemeldinger
| Dato | Melding |
|---|---|
| 23.09.2026 |
Oncoinvent ASA - Mandatory notification of trade
Reference is made to the retail offering (the "Retail Offering") announced by
Oncoinvent ASA on 22 September 2026. Please see the attached PDMR-form r...
|
| 22.09.2026 |
Oncoinvent ASA - Mandatory notification of trade
Reference is made to the private placement (the "Private Placement") announced
by Oncoinvent ASA on 22 September 2026. Please see the attached PDMR-fo...
|
| 20.05.2026 |
Oncoinvent ASA: Grant of share options to member of the Board following AGM
Oslo, Norway, 20 May 2026: Reference is made to the Annual General Meeting (the
"AGM") of Oncoinvent ASA (the "Company") earlier today where the nomin...
|
| 11.03.2026 |
Oncoinvent ASA: Grant of share options to the CEO
Oslo, Norway, 11 March 2026: The Board of Directors has today resolved to grant
CEO Øystein Soug 31,884 share options in the Company under the Company...
|
| 13.01.2026 |
Oncoinvent ASA: Grant of share options to new CFO
Oslo, Norway, 13 January 2026: Reference is made to the announcement made by
Oncoinvent ASA ("Oncoinvent" or the "Company") 31 October 2025 regarding ...
|